Brief: Bristol-Myers Squibb Announces Offer From Taisho Pharmaceutical To Purchase UPSA
Dec 19 (Reuters) -
* BRISTOL-MYERS SQUIBB ANNOUNCES OFFER FROM TAISHO
PHARMACEUTICAL
HOLDINGS CO., LTD TO PURCHASE UPSA
* BRISTOL-MYERS SQUIBB-TAISHO PHARMACEUTICAL HOLDINGS HAS
OFFERED
TO PURCHASE BRISTOL-MYERS SQUIBB'S UPSA CONSUMER HEALTH BUSINESS
FOR $1.6 BILLION
* BRISTOL-MYERS SQUIBB ESTIMATES THE POTENTIAL TRANSACTION
WOULD
BE APPROXIMATELY ($0.04) DILUTIVE TO 2019 EARNINGS
* OFFER BY TAISHO IS STRUCTURED IN FORM OF A "PUT OPTION"
AGREEMENT
* BRISTOL-MYERS -OFFER IS SUBJECT TO CO'S EXERCISE OF PUT
OPTION
FOLLOWING INFORMATION AND CONSULTATION PROCESSES WITH RELEVANT
EMPLOYEE REPRESENTATIVE BODIES
Source text for Eikon: ID:nBw4XRLDha
Further company coverage: BMY.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Taisho Pharmaceutical Holdings Co
See all newsBrief: Curi RMB Capital, Kaname Capital To Request Tokyo Court To Revise Taisho Pharmaceutical's Squeeze Out Price If Taisho Disagrees With Their Demand - Nikkei
Brief: Curi RMB Capital, Kaname Capital To Request Tokyo Court To Revise Taisho Pharmaceutical's Tender Offer Price If Taisho Disagrees Their Demand - Nikkei
Activist fund Oasis says it may take legal action over Taisho's management buyout
Brief: Curi RMB Capital Opposes Taisho Pharmaceutical HD's Management Buyout
To Retire Treasury Shares Worth 3.65% Of Outstanding Stock On April 10